Tech Center 1600 • Art Units: 1653
This examiner grants 15% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17429299 | MATERIALS AND METHODS FOR THE PREPARATION OF BACTERIAL CAPSULAR POLYSACCHARIDES | Final Rejection | The Regents of the University of California |
| 17995827 | METHOD OF PRODUCING POLYHYDROXYALKANOATE COPOLYMER MIXTURE AND TRANSFORMED MICROORGANISM | Non-Final OA | KANEKA CORPORATION |
| 18032456 | COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR RELATED DISORDERS | Non-Final OA | The Regents of the University of Michigan |
| 18329130 | METHODS FOR DETECTING ZEROVALENT NANOPARTICLE-MEDIATED OXIDATIVE STRESS IN CYANOBACTERIA | Non-Final OA | Morgan State University |
| 18076510 | MARKER COMPOSITION FOR SELECTING LIVING MODIFIED ORGANISM, LIVING MODIFIED ORGANISM, AND TRANSFORMATION METHOD | Final Rejection | INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY |
| 18025963 | COLLAGEN WITH SELECTIVE CHARACTERISTICS, COLLAGEN PRODUCTS CONTAINING SAME AND METHODS FOR PRODUCING SAME | Non-Final OA | COLLAGEN MATRIX, INC. |
| 18006800 | IMPROVEMENTS TO WASH SOLUTIONS FOR ANION EXCHANGE CHROMATOGRAPHY IN A METHOD OF PURIFICATION OF RECOMBINANTLY-PRODUCED RSV PROTEINS | Non-Final OA | Pfizer Inc. |
| 18149854 | BIOLOGICAL SINTERING OF CARBONATES WITHOUT HEAT OR PRESSURE | Non-Final OA | Biomason Inc. |
| 18259613 | LOW LIPID CONTENT OAT PROTEIN COMPOSITION WITHOUT TRACES OF ORGANIC SOLVENT OR SURFACTANT | Non-Final OA | ROQUETTE FRERES |
| 17777939 | THERMOSTABLE PHYTASE VARIANTS | Non-Final OA | DUPONT NUTRITION BIOSCIENCES APS |
| 17904690 | METHODS FOR ENGINEERING AMINO ACID AMMONIA LYASE ENZYMES AND ENZYMES THEREBY OBTAINED | Non-Final OA | Trustees of Tufts College |
| 18008820 | Engineered Bacterial Strain and Method of Use for One-Pot Vitamin C Synthesis | Non-Final OA | WiSys Technology Foundation, Inc. |
| 17613898 | GLUCONATE DEHYDRATASE ENZYMES AND RECOMBINANT CELLS | Non-Final OA | BP Corporation North America Inc. |
| 17633930 | COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMS | Non-Final OA | Vedanta Biosciences, Inc. |
| 17795930 | COMPOSITION COMPRISING CARTILAGE INGREDIENT FOR REGENERATION OF CARTILAGE AND PREPARATION METHOD THEREFOR | Final Rejection | L&C BIO Co., Ltd. |
| 18278937 | NEUROTOXIN COMPOSITIONS FOR USE IN TREATING HEADACHE | Non-Final OA | AEON Biopharma Sub, Inc. |
| 17767543 | MICROORGANISM CAPTURE FROM ANTIMICROBIAL-CONTAINING SOLUTION | Non-Final OA | MOMENTUM BIOSCIENCE LIMITED |
| 18083656 | METHODS AND KITS FOR ASSAYING A LARGE FLUID VOLUME USING FLOW CYTOMETRY | Final Rejection | HACH COMPANY |
| 18269869 | HEPATOCELLULAR CARCINOMA TREATMENTS, PROPHYLACTIC THERAPIES, AND COMPOSITIONS FOR USE THEREWITH | Non-Final OA | REPAIR BIOTECHNOLOGIES, INC. |
| 18035480 | COMPOSITIONS AND METHODS FOR TREATING SOLID CANCER | Non-Final OA | EXOXEMIS, INC. |
| 18020048 | METHOD FOR PRODUCING PROTEIN COMPOSITIONS | Non-Final OA | HOFFMAN-LA ROCHE INC. |
| 18135113 | METHOD FOR FATTY ACID ALKYL ESTER SYNTHESIS AND THEIR EXTRACTION FROM OLEAGINOUS MICROBES | Final Rejection | DEPARTMENT OF BIOTECHNOLOGY |
| 18190151 | AGAROSE-CELLULOSE NANOCOMPOSITE POROUS GEL MICROSPHERE, PREPARATION METHOD, AND APPLICATION | Non-Final OA | Hangzhou NeuroPeptide Biological Science and Technology Incorporation, Ltd. (NUPTEC) |
| 18007134 | COMPOSITIONS AND METHODS FOR TREATING BACTERIAL INFECTIONS | Final Rejection | MUCPHARM PTY LTD |
| 18017552 | A PROCESS FOR THE PURIFICATION OF PROTHROMBIN COMPLEX CONCENTRATE (PCC) AND FIX FROM COMPLETE PLASMA OR CRYO-POOR PLASMA | Final Rejection | Sartorius BIA Separations d.o.o. |
| 18150075 | COMPOSITION COMPRISING RECOMBINANT CLOSTRIDIUM NEUROTOXIN | Final Rejection | IPSEN BIOINNOVATION LIMITED |
| 17912114 | TREATMENT METHOD, PRODUCTION METHOD, AND HYDROXYAPATITE FILLER | Final Rejection | HOYA TECHNOSURGICAL CORPORATION |
| 17797907 | MODIFIED MICROORGANISM AND METHOD FOR THE IMPROVED PRODUCTION OF ECTOINE | Final Rejection | METABOLIC EXPLORER |
| 17786361 | ASSOCIATION OF FAECALIBACTERIUM PRAUSNITZII STRAIN CNCM I-4573 WITH PENTASA® FOR THE TREATMENT AND PREVENTION OF GASTROINTESTINAL INFLAMMATION | Final Rejection | INSTITUT DES SCIENCES ET INDUSTRIES DU VIVANT ET DE L'ENVIRONNEMENT |
| 17773220 | COMPOSITION COMPRISING THE EXTRACT OF TREMELLA FUCIFORMIS CULTURE MEDIUM | Final Rejection | DAEBONG LS, LTD |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy